ロード中…
Ursodeoxycholic acid use is associated with significant risk of morbidity and mortality in infants with cholestasis: A strobe compliant study
The off-label use of medications is a “right” for pediatricians, owing to lack of enough safety and effectiveness drug trials in pediatric age group. Pediatricians have to rely on their personal judicial use of medications in children. We studied off-label use of ursodeoxycholic acid (UDCA) retrospe...
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Online 論文 テキスト |
| 言語: | English |
| 出版事項: |
Wolters Kluwer Health
2020
|
| 主題: | |
| オンライン･アクセス: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035015/ https://www.ncbi.nlm.nih.gov/pubmed/32049781 http://dx.doi.org/10.1097/MD.0000000000018730 |